InvestorsHub Logo
Followers 0
Posts 4859
Boards Moderated 0
Alias Born 06/15/2010

Re: ariadndndough post# 34399

Monday, 09/23/2013 1:05:16 PM

Monday, September 23, 2013 1:05:16 PM

Post# of 80490
the chugai competition in the ALK space is disturbing. Hopefully 113's apparently benign side effect profile will differentiate the two if Chugai's drug isn't well tolerated....a big if indeed.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.